论文部分内容阅读
目的探讨在支气管扩张症患者中运用沙美特罗替卡松+小剂量红霉素治疗的作用。方法随机将近期到我院诊治的64例支气管扩张症患者分组,对照组32例单纯予沙美特罗替卡松用药,观察组32例增用小剂量红霉素治疗,针对其总治疗情况作比较和评估。结果方案实施前,两组的FEV1和FVC值对比相似,无统计学意义(P>0.05),实施后,观察组各项指标值相比对照组均有明显增高,有统计学意义(P<0.05)。两组用药期间均无严重不适,但在复发率上,观察组相对对照组更低,有统计学意义(P<0.05)。结论选用沙美特罗替卡松+小剂量红霉素方案治疗支气管扩张症,总体疗效更理想、安全,且可降低复发率,适合推广。
Objective To investigate the effects of salmeterol and tacrolimus + low-dose erythromycin in patients with bronchiectasis. Methods A total of 64 patients with bronchiectasis who were diagnosed and treated in our hospital were randomly divided into two groups. 32 patients in the control group were treated with salmeterol and fluticasone propionate, while 32 patients in the observation group were treated with low dose erythromycin. According to the total treatment Compare and evaluate. Results Before the implementation of the program, the FEV1 and FVC values of the two groups were similar, with no statistical significance (P> 0.05). After the implementation, the indexes in the observation group were significantly higher than those in the control group (P < 0.05). There was no serious discomfort during the two groups, but in the recurrence rate, the observation group was lower than the control group, with statistical significance (P <0.05). Conclusion Salmeterol + Troponin + low dose erythromycin treatment of bronchiectasis, the overall effect is more ideal, safe, and can reduce the recurrence rate, suitable for promotion.